The relationship of the bronchodilator response phenotype to poor asthma control in children with normal spirometry

Stanley P Galant1, Tricia Morphew, Robert L Newcomb

  • 1Children's Hospital of Orange County(CHOC), Orange, CA, USA. spg1505@aol.com

The Journal of Pediatrics
|January 15, 2011
PubMed

Insights

A bronchodilator response (BDR) of 10% or higher is linked to poor asthma control in children. This finding offers an objective measure for assessing asthma control, especially in those not yet on medication and with normal spirometry.

Area of Science:

  • Pediatric Pulmonology
  • Respiratory Medicine
  • Clinical Asthma Research

Background:

  • Poorly controlled asthma in children presents diagnostic challenges, particularly with normal baseline spirometry.
  • Identifying objective markers for asthma control is crucial for timely intervention.

Purpose of the Study:

  • To investigate the association between clinical indicators of poor asthma control and bronchodilator response (BDR) phenotypes in children.
  • To evaluate the utility of BDR as an objective measure in children with normal spirometry.

Main Methods:

  • Assessed clinical indices of poorly controlled asthma in children with asthma.
  • Performed pre- and post-bronchodilator spirometry to determine BDR percentage.
  • Utilized multivariate logistic regression to analyze relationships between clinical indices and BDR thresholds (≥ 8%, ≥ 10%, ≥ 12%).

Main Results:

  • In controller-naïve children, significant associations were found between poor asthma control indicators and BDR phenotypes ≥ 10% and ≥ 12%.
  • Factors linked to positive BDR included younger age, atopy, nocturnal symptoms (females), beta-agonist use, and exercise limitation.
  • These relationships were particularly evident in the controller-naïve population.

Conclusions:

  • A bronchodilator response (BDR) phenotype of ≥ 10% is significantly associated with poor asthma control.
  • This BDR phenotype serves as a potentially valuable objective tool for assessing asthma control in controller-naïve children, even with normal pre-bronchodilator spirometry.
Abstract

Related Concept Videos

Chronic Obstructive Pulmonary Disease III: Chronic Bronchitis Features01:24

Chronic Obstructive Pulmonary Disease III: Chronic Bronchitis Features

Chronic bronchitis is a key phenotype of chronic obstructive pulmonary disease (COPD), characterized by airway-centered inflammation and mucus overproduction. It develops from long-term exposure to harmful particles or gases, most commonly cigarette smoke, which triggers a persistent inflammatory response.Cellular and Structural ChangesInflammation initially affects the large bronchi and later the smaller airways, with infiltration by immune cells, including neutrophils, macrophages, and...
Asthma I: Introduction01:28

Asthma I: Introduction

Asthma is a chronic inflammatory disorder of the airways characterized by variable airflow obstruction and heightened bronchial responsiveness to a wide range of triggers. The underlying inflammation leads to airway swelling, mucus hypersecretion, and smooth muscle constriction, all of which narrow the airway lumen and impede airflow. Clinically, asthma presents with recurrent episodes of wheezing, shortness of breath, chest tightness, and coughing, symptoms that typically vary in intensity and...
Asthma-II: Pathophysiology and Classification01:26

Asthma-II: Pathophysiology and Classification

Asthma is a prevalent chronic respiratory condition marked by inflammation and hyperresponsiveness of the airways. Its pathophysiology involves complex interactions among inflammatory pathways, immune responses, and neural mechanisms.
Additionally, environmental and genetic factors play crucial roles in determining an individual's susceptibility to asthma and the severity of their condition.
Critical processes in asthma pathophysiology include:
Asthma: Pathogenesis and Management01:20

Asthma: Pathogenesis and Management

Asthma is a chronic pulmonary condition involving inflammation of the airways, hyper-reactivity, and reversible obstruction of the airways. This condition can significantly impact a person's quality of life, making breathing difficult and leading to distressing symptoms.
Asthma is classified as allergic and non-allergic. Allergens such as dust mites, pollen, and pet dander trigger allergic asthma, while factors like cold air, intense emotions, or exercise can induce non-allergic asthma.
Antiasthma Drugs: β2-Adrenoceptor Agonists01:25

Antiasthma Drugs: β2-Adrenoceptor Agonists

Bronchodilators are critical in managing asthma, a chronic respiratory condition characterized by airway constriction due to inflammation and hyper-reactivity. Specifically, bronchodilators ease this constriction by relaxing the bronchial muscles, facilitating easier breathing.
One class of bronchodilators includes β2-adrenoceptor agonists. These agents target the β2-adrenoceptors located on bronchial smooth muscle cells. By stimulating these receptors, β2-agonists induce relaxation in these...
COPD: Management Using Bronchodilators and Corticosteroids01:26

COPD: Management Using Bronchodilators and Corticosteroids

Chronic obstructive pulmonary isease (COPD) involves a group of progressive lung disorders characterized by persistent airflow limitation and chronic respiratory symptoms. Asthma-COPD Overlap Syndrome (ACOS), encompassing features of both asthma and Chronic obstructive pulmonary disease (COPD), is a group of progressive lung disorders that includes chronic bronchitis, emphysema, and refractory (non-reversible) asthma. ACOS leads to complex clinical presentations that combine the inflammatory...